Literature DB >> 19219631

Sustained lower rates of HRT prescribing and breast cancer incidence in Australia since 2003.

Karen Canfell, Emily Banks, Mark Clements, Yoon Jung Kang, Aye Moa, Bruce Armstrong, Valerie Beral.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19219631     DOI： 10.1007/s10549-009-0331-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  7 in total

Review 1.  Postmenopausal hormone therapy: an Endocrine Society scientific statement.

Authors:  Richard J Santen; D Craig Allred; Stacy P Ardoin; David F Archer; Norman Boyd; Glenn D Braunstein; Henry G Burger; Graham A Colditz; Susan R Davis; Marco Gambacciani; Barbara A Gower; Victor W Henderson; Wael N Jarjour; Richard H Karas; Michael Kleerekoper; Roger A Lobo; JoAnn E Manson; Jo Marsden; Kathryn A Martin; Lisa Martin; JoAnn V Pinkerton; David R Rubinow; Helena Teede; Diane M Thiboutot; Wulf H Utian
Journal:  J Clin Endocrinol Metab       Date:  2010-06-21       Impact factor: 5.958

2.  A systematic review of non-hormonal treatments of vasomotor symptoms in climacteric and cancer patients.

Authors:  Juergen Drewe; Kathleen A Bucher; Catherine Zahner
Journal:  Springerplus       Date:  2015-02-10

3.  Menopausal Hormone Therapy use and breast cancer risk by receptor subtypes: Results from the New South Wales Cancer Lifestyle and EvaluAtion of Risk (CLEAR) study.

Authors:  Usha Salagame; Emily Banks; Dianne L O'Connell; Sam Egger; Karen Canfell
Journal:  PLoS One       Date:  2018-11-07       Impact factor: 3.240

4.  Hormone-Replacement Therapy and Its Association with Breast Cancer Subtypes: A Large Retrospective Cohort Study.

Authors:  Vered Rosenberg; Avital Bareket-Samish; Gabriel Chodick; Nava Siegelmann-Danieli
Journal:  Int J Womens Health       Date:  2021-12-03

5.  A genome-wide association study to identify genetic susceptibility loci that modify ductal and lobular postmenopausal breast cancer risk associated with menopausal hormone therapy use: a two-stage design with replication.

Authors:  Rebecca Hein; Dieter Flesch-Janys; Norbert Dahmen; Lars Beckmann; Sara Lindström; Nils Schoof; Kamila Czene; Kirstin Mittelstraß; Thomas Illig; Petra Seibold; Sabine Behrens; Keith Humphreys; Jingmei Li; Jianjun Liu; Janet E Olson; Xianshu Wang; Susan E Hankinson; Thérèse Truong; Florence Menegaux; Isabel Dos Santos Silva; Nichola Johnson; Shou-Tung Chen; Jyh-Cherng Yu; Argyrios Ziogas; Vesa Kataja; Veli-Matti Kosma; Arto Mannermaa; Hoda Anton-Culver; Chen-Yang Shen; Hiltrud Brauch; Julian Peto; Pascal Guénel; Peter Kraft; Fergus J Couch; Douglas F Easton; Per Hall; Jenny Chang-Claude
Journal:  Breast Cancer Res Treat       Date:  2013-02-20       Impact factor: 4.872

6.  A population-based study of breast cancer prevalence in Australia: predicting the future health care needs of women living with breast cancer.

Authors:  Xue Qin Yu; Roberta De Angelis; Qingwei Luo; Clare Kahn; Nehmat Houssami; Dianne L O'Connell
Journal:  BMC Cancer       Date:  2014-12-11       Impact factor: 4.430

7.  Use of Menopausal Hormone Therapy and Bioidentical Hormone Therapy in Australian Women 50 to 69 Years of Age: Results from a National, Cross-Sectional Study.

Authors:  Louiza S Velentzis; Emily Banks; Freddy Sitas; Usha Salagame; Eng Hooi Tan; Karen Canfell
Journal:  PLoS One       Date:  2016-03-23       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.